The NyokAssist device, from China, had few adverse outcomes by 30 days. More devices—and more trials—are on the way.
PARTNER 3 may notch a win for transcatheter aortic valve replacement in patients with low surgical risk, according to experts ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback